Koufakis, T., Metallidis, S., Zebekakis, P., Ajjan, R. A., & Kotsa, K. (2020). Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable? J Diabetes Sci Technol.

Koufakis, Theocharis, Symeon Metallidis, Pantelis Zebekakis, Ramzi A. Ajjan, and Kalliopi Kotsa. "Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?" J Diabetes Sci Technol 2020.

Koufakis, Theocharis, et al. "Sodium-Glucose Cotransporter 2 Inhibitors in the Era of COVID-19 Pandemic: Is the Benefit to Risk Ratio Still Favorable?" J Diabetes Sci Technol 2020.